Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | THRB | P10828 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 2/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | SNCA | P37840 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | SENP2 | Q9HC62 | 4/20 | 0.84 |
| ▸ | SENP1 | Q9P0U3 | 4/20 | 0.84 |
| ▸ | SUMO2 | P61956 | 3/20 | 0.84 |
| ▸ | SUMO1 | P63165 | 3/20 | 0.84 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.84 |
| ▸ | SLC7A11 | Q9UPY5 | 5/20 | 0.79 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.74 |
| ▸ | GLB1 | P16278 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Congo Red Free Acid SCHEMBL29825625 | 1.00 | APP (1.00) | APPALDH1A1THRBHPGDALOX12 | |
| Congo Red Free Acid SCHEMBL29350758 | 1.00 | APP (1.00) | APPALDH1A1THRBHPGDALOX12 | |
| Congo Red Free Acid SCHEMBL1254806 | 1.00 | APP (1.00) | APPALDH1A1THRBHPGDALOX12 | |
| Congo Red Free Acid SCHEMBL17272057 | 0.99 | APP (0.97) | APPALDH1A1THRBHPGDALOX12 | |
| Congo Red Free Acid SCHEMBL5147845 | 0.99 | APP (0.97) | APPALDH1A1THRBHPGDALOX12 | |
| Congo Red Free Acid SCHEMBL29415044 | 0.99 | APP (0.97) | APPALDH1A1THRBHPGDALOX12 | |
| Congo Red Free Acid SCHEMBL326268 | 0.99 | APP (0.97) | APPALDH1A1THRBHPGDALOX12 | |
| SCHEMBL15120269 | 0.94 | APP (0.88) | APPALDH1A1THRBHPGDALOX12 | |
| SCHEMBL18044243 | 0.94 | APP (0.88) | APPALDH1A1THRBHPGDALOX12 | |
| SCHEMBL16994623 | 0.93 | APP (0.86) | APPALDH1A1THRBHPGDALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3636600-B1 | A SORPTION COMPOSITION FOR COMPLEX WATER PURIFICATION | EWI BVBA (BE) | 2022-11-30 | — | — | EP | claimed |
| EP-3636600-A1 | A SORPTION COMPOSITION FOR COMPLEX WATER PURIFICATION | EWI bvba (BE) | 2020-04-15 | — | — | EP | claimed |
| EP-2567225-A2 | LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS | Virginia Tech Intellectual Properties, Inc. (US) | 2013-03-13 | — | — | EP | claimed |
| WO-2011140215-A2 | LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2011-11-10 | — | — | WO | claimed |
| US-20110275558-A1 | LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2011-11-10 | — | — | US | claimed |
| US-20230181744-A1 | COMPOUND FOR PREVENTING OR TREATING LIPID METABOLISM-RELATED DISEASES | FUDAN UNIVERSITY (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20230181744-A1 | COMPOUND FOR PREVENTING OR TREATING LIPID METABOLISM-RELATED DISEASES | FUDAN UNIVERSITY (CN) | 2023-06-15 | — | — | US | disclosed |
| EP-3636600-B1 | A SORPTION COMPOSITION FOR COMPLEX WATER PURIFICATION | EWI BVBA (BE) | 2022-11-30 | — | — | EP | disclosed |
| US-20220054500-A1 | Inhibition of Thymine DNA Glycosylase in the Treatment of Cancer | INSTITUT CURIE (FR) | 2022-02-24 | — | — | US | disclosed |
| US-20210331122-A1 | TWO-DIMENSIONAL NANOPOROUS COVALENT ORGANIC FRAMEWORK FOR SELECTIVE SEPARATION AND FILTRATION MEMBRANE FORMED THEREFROM | UNIVERSITY OF WYOMING (US) | 2021-10-28 | — | — | US | disclosed |
| US-20210275548-A1 | NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF | ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) | 2021-09-09 | — | — | US | disclosed |
| US-20210253651-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND-ENCAPSULATING FERRITIN | AJINOMOTO CO., INC. (JP) | 2021-08-19 | — | — | US | disclosed |
| US-20110275558-A1 | LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2011-11-10 | — | — | US | disclosed |
| US-20100193021-A1 | THIN FILM SOLAR CELL AND METHOD OF MANUFACTURING THE SAME | LG DISPLAY CO., LTD. (KR) | 2010-08-05 | — | — | US | disclosed |
| US-7485706-B2 | Neurodegenerative protein aggregation inhibition methods and compounds | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2009-02-03 | — | — | US | disclosed |
| US-7264932-B2 | Nuclease inhibitor cocktail | APPLERA CORPORATION (US) | 2007-09-04 | — | — | US | disclosed |
| US-7264932-B2 | Nuclease inhibitor cocktail | APPLERA CORPORATION (US) | 2007-09-04 | — | — | US | disclosed |
| US-20070032418-A1 | Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same | AMBION, INC (US) | 2007-02-08 | — | — | US | disclosed |
| US-20070032418-A1 | Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same | AMBION, INC (US) | 2007-02-08 | — | — | US | disclosed |
| EP-0069301-A1 | Process for the preparation of a polyvinyl alcohol complex compound, and the polyvinyl alcohol complex compound so prepared | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230181744-A1 | COMPOUND FOR PREVENTING OR TREATING LIPID METABOLISM-RELATED DISEASES | MAP1LC3B, MAP1LC3A, SQSTM1 | APP 264/4885ALDH1A1 897/4885THRB 1791/4885 |
| US-20070032418-A1 | Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same | RNASE1, RNASEH1, RNASEL | APP 2583/4885ALDH1A1 2603/4885THRB 3297/4885 |
| US-20210275548-A1 | NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF | POLG, POLB, POLA1 | APP 3911/4885ALDH1A1 3745/4885THRB 2774/4885 |
| US-20210253651-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND-ENCAPSULATING FERRITIN | FTH1, HAMP, FECH | APP 1199/4885ALDH1A1 3291/4885THRB 1443/4885 |
| US-20220054500-A1 | Inhibition of Thymine DNA Glycosylase in the Treatment of Cancer | UNG, MPG, TYMP | APP 1323/4885ALDH1A1 1403/4885THRB 1508/4885 |
| US-20110275558-A1 | LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS | LANCL2, ACSL1, LANCL1 | APP 4090/4885ALDH1A1 3626/4885THRB 602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.